2021-11-15-投中研究院-投中统计_35家中企实现IPO_退出回报率逐渐回升_27页_3mb

报告摘要

Key Findings for October 2021: China reported a total of 35 IPOs across A-share, H-share, and US markets, with a slight decrease in number but an increase in fundraising scale.
Market Highlights: A-share IPO fundraising rose by 44.21%, led by companies like Big Alpha Bio and Kefu Medical. Healthcare and manufacturing were dominant sectors, raising 166.87 billion and 130.830 billion yuan, respectively. Zhejiang, Jiangsu, and Beijing contributed the most to IPO activity.
VC/PE Performance: Investment penetration reached 65.71%, with IPOs showing improved average returns for venture capital and private equity firms.
Regional Focus: Zhejiang led in both IPO count (7) and fundraising (69.490 billion yuan), followed by Jiangsu and Beijing.
Sector Distribution: Manufacturing, healthcare, and chemicals were top industries, accounting for 70.80% of total IPO funds.
Notable Cases: MicroTech Medical, focused on diabetes devices, achieved a significant H-share IPO with strong investment returns.
Regulatory Moves: Discussions centered on enhancing IPO disclosure under the registration-based system to improve market quality and investor transparency.

展开完整摘要

试读结束，高清完整版pdf/doc/ppt,请点下载